Literature DB >> 3915250

Sputum cytology by the Saccomanno method in diagnosing lung malignancy.

E K Risse, M A van't Hof, R N Laurini, P G Vooijs.   

Abstract

From 1,488 patients, satisfactory sputum was available for cytologic diagnosis. Overall diagnoses were correct in 85.4% of patients, false negative in 193 patients (13.0%), and false positive in 24 patients (1.6%). In patients with a malignant lung process, cytologic diagnoses were correct in 228 patients (54.2%) and false negative in 193 patients (45.8%). In patients with primary lung cancer, the proportion of correct positive diagnoses increased from 0.47 to 0.87 with one to five sputum specimens examined. In patients with metastatic disease, the figures were 0.35 with one specimen examined and 0.38 with two and more sputum specimens. Cytologic typing accuracy was 67% for large-cell carcinomas, 73% for adenocarcinomas, 91% for small-cell lung cancers, and 98% for squamous-cell carcinomas. For the clinically most relevant groups of nonsmall-cell lung cancer and small-cell lung cancer, these figures were 99% and 91%, respectively.

Entities:  

Mesh:

Year:  1985        PMID: 3915250     DOI: 10.1002/dc.2840010406

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

Review 1.  Sputum examination for early detection of lung cancer.

Authors:  F B J M Thunnissen
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Inflammation, oxidative stress, and higher expression levels of Nrf2 and NQO1 proteins in the airways of women chronically exposed to biomass fuel smoke.

Authors:  Nandan Kumar Mondal; Hirak Saha; Bidisha Mukherjee; Neetu Tyagi; Manas Ranjan Ray
Journal:  Mol Cell Biochem       Date:  2018-01-24       Impact factor: 3.396

3.  ACP Broadsheet No 140: July 1993. Techniques in pulmonary cytopathology.

Authors:  J A Young
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

Review 4.  Molecular sputum analysis for the diagnosis of lung cancer.

Authors:  A J Hubers; C F M Prinsen; G Sozzi; B I Witte; E Thunnissen
Journal:  Br J Cancer       Date:  2013-07-18       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.